Taiwan Access to capital is the difference between life and death for small biotechs and life science start-ups. But in an industry with high levels of failure and decades-long development cycles, finding the right investors – those with sufficiently deep pockets and enough of an appetite for risk – can be…
See our Cookie Privacy Policy Here
